Covered recipient · General Payments record
SARAH WARSETSKY
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,304.09
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.67 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $104.24 | 5 |
| ABBVIE INC. | $100.57 | 5 |
| Sumitomo Pharma America, Inc. | $27.14 | 2 |
| Daiichi Sankyo Inc. | $27.00 | 1 |
| CooperSurgical, Inc. | $15.92 | 1 |
| PFIZER INC. | $13.41 | 1 |
| MILLICENT US INC | $13.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.05 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311121 | CMS |
| ABBVIE INC. | $19.05 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311123 | CMS |
| ABBVIE INC. | $19.37 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311125 | CMS |
| ABBVIE INC. | $18.30 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311127 | CMS |
| ABBVIE INC. | $21.80 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106311129 | CMS |
| Astellas Pharma US Inc | $20.33 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139283174 | CMS |
| Astellas Pharma US Inc | $20.20 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139360219 | CMS |
| Astellas Pharma US Inc | $23.90 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139390334 | CMS |
| Astellas Pharma US Inc | $17.18 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139410295 | CMS |
| Astellas Pharma US Inc | $22.63 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139437034 | CMS |
| CooperSurgical, Inc. | $15.92 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150786069 | CMS |
| Daiichi Sankyo Inc. | $27.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089496684 | CMS |
| MILLICENT US INC | $13.39 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150913145 | CMS |
| PFIZER INC. | $13.41 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131052153 | CMS |
| Sumitomo Pharma America, Inc. | $13.46 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148933638 | CMS |
| Sumitomo Pharma America, Inc. | $13.68 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148933640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.